A new report from the American Cancer Society shows 7 in 10 cancer patients are living at least 5 years post-diagnosis.

Survival rates for all cancers are increasing, but threats to federal funding and access to care jeopardize these advances.

UCLA researchers have developed a CAR-NKT cell therapy that has shown to be more effective than current immunotherapies at fighting cancer in tumor samples from late-stage triple-negative breast ...